Evidence map›Paper›PMID 33419891›Full record

Observational studyThe European respiratory journal2021

Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study.

Sabina A Guler, Lukas Ebner, Catherine Aubry-Beigelman, Pierre-Olivier Bridevaux, Martin Brutsche, Christian Clarenbach, Christian Garzoni, Thomas K Geiser, Alexandra Lenoir, Marco Mancinetti and 8 more

2 registry-linked trialsOpen access · bronzeAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in The European respiratory journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 254 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
254citing papers in PubMed, 8 pooled it
55.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05302973 nacompletednot on this map

Effects of Aerobic Exercise in People With Post-COVID-19: a Randomized Controlled Trial

TypeinterventionalSponsorIstituti Clinici Scientifici Maugeri SpARan2021 to 2023Enrolled30ConditionsCOVID-19ArmsConventional rehabilitation, Aerobic exercise
NCT05381714 completednot on this mapstarted 2022, after this paper: background citation

Long-Term Respiratory and Peripheral Muscle Strength and Respiratory Function in Young COVID-19 Patients: A Cross-Sectional Study

Typeobservational_patient_registrySponsorKarabuk UniversityRan2022 to 2023Enrolled100ConditionsCOVID-19
3 · Its place in the literature

Who cites it

254 citing papers in PubMed, 8 syntheses or guidelines pooled it, 420 citations in OpenAlex.

  1. Pooled it
  2. Recovery of lung function during the first year after COVID-19: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2025
    Pooled it
  3. Pooled it
  4. Post-COVID-19 dyspnoea and pulmonary imaging: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2023
    Pooled it
  5. Pooled it
  6. Pooled it
  7. ESCMID rapid guidelines for assessment and management of long COVID.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022
    Guideline
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. LongitudinalJournal of magnetic resonance imaging : JMRI · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Methylprednisolone in the management of post-COVID-19 interstitial lung disease: A randomized trial (STERCOV-ILD).Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2026
    Article
  19. Article
  20. Incentive Spirometer in COVID-19: A Systematic Review.Journal of clinical medicine · 2026
    Review

194 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 10 institutions in 1 country.

Sabina A GulerDept of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.ORCID https://orcid.org/0000-0002-9833-5911
Lukas EbnerDept of Diagnostic, Interventional and Pediatric Radiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Catherine Aubry-BeigelmanRadiodiagnostic and Interventional Radiology, CHUV-University Hospital, Lausanne, Switzerland.
Pierre-Olivier BridevauxService de Pneumologie, Hôpital du Valais, Sion, Switzerland.
Martin BrutscheLung Center, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Christian ClarenbachDept of Pneumology, University Hospital Zurich, Zurich, Switzerland.ORCID https://orcid.org/0000-0003-2158-2321
Christian GarzoniClinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland.
Thomas K GeiserDept of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Alexandra LenoirDivision of Pulmonary Medicine, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland.ORCID https://orcid.org/0000-0003-2189-6507
Marco MancinettiDept of Internal Medicine, University and Hospital of Fribourg, Fribourg, Switzerland.
Bruno NacciniDept of Pulmonary Medicine, Clinica Luganese Moncucco, Lugano, Switzerland.
Sebastian R OttDept of Pulmonary Medicine, St. Claraspital AG, Basel, Switzerland.
Lise PiquilloudAdult Intensive Care Unit, University Hospital and University of Lausanne, Lausanne, Switzerland.
Maura PrellaDivision of Pulmonary Medicine, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland.
Yok-Ai QueDept of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Paula M SoccalDivision of Pulmonary Medicine, Geneva University Hospitals, Geneva, Switzerland.
Christophe von GarnierDivision of Pulmonary Medicine, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland.
Manuela Funke-ChambourDept of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.ORCID https://orcid.org/0000-0003-3417-5872
University of Bern · CHUniversity of Lausanne · CHClinica Luganese Moncucco · CHHôpital du Valais · CHKantonsspital St. Gallen · CHSt. Claraspital · CHUniversity Hospital of Geneva · CHUniversity Hospital of Lausanne · CHUniversity Hospital of Zurich · CHUniversity of Fribourg · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe infectious coronavirus disease 2019 (COVID-19) pandemic is an ongoing global healthcare challenge. Up to one-third of hospitalised patients develop severe pulmonary complications and acute respiratory distress syndrome. Pulmonary outcomes following COVID-19 are unknown.

methodsThe Swiss COVID-19 lung study is a multicentre prospective cohort investigating pulmonary sequelae of COVID-19. We report on initial follow-up 4 months after mild/moderate or severe/critical COVID-19 according to the World Health Organization severity classification.

results113 COVID-19 survivors were included (mild/moderate n=47, severe/critical n=66). We confirmed several comorbidities as risk factors for severe/critical disease. Severe/critical disease was associated with impaired pulmonary function,

conclusions4 months after severe acute respiratory syndrome coronavirus 2 infection, severe/critical COVID-19 was associated with significant functional and radiological abnormalities, potentially due to small-airway and lung parenchymal disease. A systematic follow-up for survivors needs to be evaluated to optimise care for patients recovering from COVID-19.

Indexed as

COVID-19HumansLungProspective StudiesRespiratory Function TestsSARS-CoV-2Switzerland

Identifiers

PMID33419891
PMCPMC8082329
OpenAlexW3120870987

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.